401(k) millionaires hit a record high — and it seems this ‘slacker’ generation is finally getting its act together
The trick: Starting early and contributing “consistently” Source link...
MARKET
Are medical bills making you sick? Here’s why it’s worth challenging them.
Next time you get a medical bill that makes no sense or threatens to blow your budget, there may be a surprisingly simple remedy: Pick up the phone and call the billing office. Source link...
Nvidia’s stock-buyback plan is one of the biggest of 2024. Is that a good thing?
Nvidia is “taking shareholder interests to heart,” one analyst says, but another expert notes the buyback program is a strange look when the CEO is selling stock. Source link...
Intel’s stock soars on hope of business split. Analyst says ‘don’t fall for it.’
Intel shares are on track for their best day in nearly two years after reports indicated the beleaguered company is considering various options for the business. Source link...
Consumer sentiment improves a bit more in late August
Index rises to 67.9 in final reading from 67.8 preliminary Source link...
This search AI company’s stock is tanking as customer commitments fell short
Elastic beat quarterly earnings expectations but provided a revenue outlook that was below expectations. Source link...
How golfing — and putting in particular — can be applied to investing, according to one strategist
Research showing how the brain reacts to putting can be applied to investing says DataTrek Source link...
Ulta’s stock slump after disappointing earnings is a buying opportunity, analysts say
The selloff in Ulta Beauty Inc.’s shares after the company’s weaker-than-expected second-quarter earnings is a buying opportunity for investors, who now include Warren Buffett, investment banking firm D.A. Davidson said Friday. Source link...
Do policy makers have a ‘death wish’ for the U.S. dollar?
The greenback’s special status is a “huge advantage” that feels like it’s being thrown away, one strategist notes. Source link...
Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic. Source link...
